COLOPLAST A/S/ADR (OTCMKTS:CLPBY) Reaches New 12-Month High at $12.65

COLOPLAST A/S/ADR (OTCMKTS:CLPBY)’s stock price reached a new 52-week high on Wednesday . The stock traded as high as $12.65 and last traded at $12.63, with a volume of 41028 shares trading hands. The stock had previously closed at $12.36.

Separately, ValuEngine lowered COLOPLAST A/S/ADR from a “hold” rating to a “sell” rating in a research report on Wednesday.

The stock has a market capitalization of $27.30 billion, a price-to-earnings ratio of 42.13 and a beta of 0.49. The company has a quick ratio of 0.90, a current ratio of 1.29 and a debt-to-equity ratio of 0.02. The firm has a 50-day moving average of $12.04 and a two-hundred day moving average of $11.91.

COLOPLAST A/S/ADR (OTCMKTS:CLPBY) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $0.08 earnings per share for the quarter. The firm had revenue of $687.96 million for the quarter. COLOPLAST A/S/ADR had a return on equity of 69.30% and a net margin of 21.62%.

About COLOPLAST A/S/ADR (OTCMKTS:CLPBY)

Coloplast A/S develops and markets intimate healthcare products and services worldwide. The company operates through three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit to individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.

Recommended Story: Mutual Funds

Receive News & Ratings for COLOPLAST A/S/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for COLOPLAST A/S/ADR and related companies with MarketBeat.com's FREE daily email newsletter.